These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23219902)

  • 1. Mutant huntingtin affects endocytosis in striatal cells by altering the binding of AP-2 to membranes.
    Borgonovo JE; Troncoso M; Lucas JJ; Sosa MA
    Exp Neurol; 2013 Mar; 241():75-83. PubMed ID: 23219902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute intrastriatal administration of quinolinic acid affects the expression of the coat protein AP-2 and its interaction with membranes.
    Borgonovo J; Seltzer A; Sosa MA
    J Neural Transm (Vienna); 2009 Oct; 116(10):1201-8. PubMed ID: 19597933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways.
    Velier J; Kim M; Schwarz C; Kim TW; Sapp E; Chase K; Aronin N; DiFiglia M
    Exp Neurol; 1998 Jul; 152(1):34-40. PubMed ID: 9682010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo.
    Trushina E; Singh RD; Dyer RB; Cao S; Shah VH; Parton RG; Pagano RE; McMurray CT
    Hum Mol Genet; 2006 Dec; 15(24):3578-91. PubMed ID: 17142251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin and dopamine D1 receptor activation increase huntingtin's association with endosomes in immortalized neuronal cells of striatal origin.
    Kim M; Velier J; Chase K; Laforet G; Kalchman MA; Hayden MR; Won L; Heller A; Aronin N; Difiglia M
    Neuroscience; 1999; 89(4):1159-67. PubMed ID: 10362304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
    Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
    J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's disease.
    Laprairie RB; Kelly ME; Denovan-Wright EM
    Neuropharmacology; 2013 Sep; 72():47-57. PubMed ID: 23602984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of neuron-specific huntingtin aggregates in human huntingtin knock-in mice.
    Sawada H; Ishiguro H; Nishii K; Yamada K; Tsuchida K; Takahashi H; Goto J; Kanazawa I; Nagatsu T
    Neurosci Res; 2007 Apr; 57(4):559-73. PubMed ID: 17335925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors.
    Fan MM; Zhang H; Hayden MR; Pelech SL; Raymond LA
    J Neurochem; 2008 Feb; 104(3):790-805. PubMed ID: 17971125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type huntingtin protects neurons from excitotoxicity.
    Leavitt BR; van Raamsdonk JM; Shehadeh J; Fernandes H; Murphy Z; Graham RK; Wellington CL; Raymond LA; Hayden MR
    J Neurochem; 2006 Feb; 96(4):1121-9. PubMed ID: 16417581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets.
    Zhai W; Jeong H; Cui L; Krainc D; Tjian R
    Cell; 2005 Dec; 123(7):1241-53. PubMed ID: 16377565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 ameliorates cell death features in Huntington's disease striatal cell models.
    Rosenstock TR; de Brito OM; Lombardi V; Louros S; Ribeiro M; Almeida S; Ferreira IL; Oliveira CR; Rego AC
    Neurochem Int; 2011 Oct; 59(5):600-9. PubMed ID: 21703318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
    Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor-mediated PIP5K activation to produce PI(4,5)P₂ is essential for AMPA receptor endocytosis during LTD.
    Unoki T; Matsuda S; Kakegawa W; Van NT; Kohda K; Suzuki A; Funakoshi Y; Hasegawa H; Yuzaki M; Kanaho Y
    Neuron; 2012 Jan; 73(1):135-48. PubMed ID: 22243752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
    Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
    Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo.
    Charvin D; Roze E; Perrin V; Deyts C; Betuing S; Pagès C; Régulier E; Luthi-Carter R; Brouillet E; Déglon N; Caboche J
    Neurobiol Dis; 2008 Jan; 29(1):22-9. PubMed ID: 17905594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.
    Wang J; Gines S; MacDonald ME; Gusella JF
    BMC Neurosci; 2005 Jan; 6():1. PubMed ID: 15649316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.